Prof. Dor Salomon promoted to Associate Professor
Department of Clinical Microbiology and Immunology
Prof. Dor Salomon is at the Department of Clinical Microbiology and Immunology. He completed his PhD (Dean’s direct track) at Tel Aviv University, followed by a Postdoctoral fellowship at the University of Texas Southwestern Medical Center. Dr. Salomon was awarded the NIH Pathway to Independence Award (K99/R00) and was also awarded the Alon Fellowship for young investigators and the prestigious European Research Council (ERC) starting grant. During the period of COVID-19 quarantine, he organized a virtual international conference with over 400 participants, named T6SympoZOOM.
Prof. Salomon works on antibacterial treatment. The World Health Organization predicts that by 2050, multidrug-resistant pathogens will become the leading cause of death worldwide. To prevent this catastrophe, the development of novel antibacterial treatments is necessary. Dr. Salomon is employing multi-disciplinary approaches to study mechanisms and toxins that are used by bacteria to neutralize their bacterial competitors. By adapting and custom-engineering these natural antibacterial mechanisms, Dr. Salomon is developing next-generation antibacterial treatments and prophylactics.
More information at: dorsalomonlab.sites.tau.ac.il